**Stock Gumshoe Reviews Beta Release -- Please Contact With Comments/Questions**

Category: Biotech/Medical

This category contains 4 newsletters currently ready to be reviewed. Contact us to add more titles to the list or just submit a new review here for any newsletter.

Access Group

Overall Rating55555
Performance of Picks/Advice55555
Consistency55555
Interesting to Read/Educational55555
Customer Service55555
Value for the Money55555
Publisher: ,

Healthcare-focused newsletter, recommends stocks primarily of emerging device and biotech companies.

S&A FDA Report

Overall Rating33333
Performance of Picks/Advice2.52.52.52.52.5
Consistency33333
Interesting to Read/Educational44444
Customer Service44444
Value for the Money33333
Publisher:

Recommends trades (long and short) based on clinical trials, particularly for smaller pharmaceutical and biotech companies.

Phase 1 Investor

Overall Rating1.831.831.831.831.83
Performance of Picks/Advice1.831.831.831.831.83
Consistency1.671.671.671.671.67
Interesting to Read/Educational2.832.832.832.832.83
Customer Service3.23.23.23.23.2
Value for the Money1.671.671.671.671.67
Publisher:

Focuses on small, potential explosive growth companies, mostly in tech and biotech.

Biotech Breakthrough Stock Report

Overall RatingNo Ratings
Performance of Picks/AdviceNo Ratings
ConsistencyNo Ratings
Interesting to Read/EducationalNo Ratings
Customer ServiceNo Ratings
Value for the MoneyNo Ratings
Publisher:

Biotech stock picking service.

http://www.stockgumshoe.com/reviews/comments/feed/